EYE

National Vision Holdings, Inc. Health Care Ophthalmic Goods Russell 3000
$16.59Close $1.3BMarket cap $15.44 – $29.4652-week range Nov 12, 2026Next report · before the open

Highlights

Strengths

  • Earnings growing EPS +41% year on year

Cautions

  • Not in an uptrend 0 of 8 trend conditions
  • Lagging the market RS 7 · weaker than 93% of stocks over 12 months
  • Far from its high 44% below its 52-week high
  • Results soon Nov 12, 2026, in 11 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Jan 3, 2026 · filed Aug 13, 2026
Off 12-month high 44%
1wk down 11.1% price change
1mo up 1.3% price change
12-month return down 37% market up 11% · its own down 49%
F-score — — Not assessed
Altman Z 1.88 Moderate risk
P/E 44.5× price / earnings
PEG — P/E / EPS growth
P/B 1.5× price / book
Earnings yield up 3.9% EBIT / enterprise value
Cheaper than 69% of the market · cheap
Revenue growth up 9% year on year
EPS growth up 41% latest quarter · -72 pts
Sales growth up 3% latest quarter · -4 pts
ROE up 4% return on equity
Free cash margin up 4% $73.5M FCF
D/E 0.26 long-term debt / equity
Net debt / EBITDA 1.2×
Interest cover —EBIT / interest
Piotroski tests

Repair signals

  • Long-term debt down 7% ($0.2B → $0.2B)

Trade setup

ATR% 5.1% $0.85 a day · 2×ATR $14.90
RS 7 / 99 vs the universe
Trend 0 / 8 trend template
Relative volume 1.2× vs 50-day average
Up/down volume 1.35 50 sessions
Implied move — no option chain · report Nov 12, 2026
Trend template · 0 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Aug 12, 2026
Last shock Aug 12, 2026-12% in one session2.8× volumeon results-15% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $2.0B +9% on FY2024
$0 $2.5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.7B FY2021 · $2.1B FY2022 · $1.6B FY2023 · $1.8B FY2024 · $1.8B FY2025 · $2.0B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $29.6M back to a profit
-$100M $0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $36.3M FY2021 · $128.2M FY2022 · $42.1M FY2023 · -$65.9M FY2024 · -$28.5M FY2025 · $29.6M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $73.5M +93% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $158.2M FY2021 · $163.4M FY2022 · $5.7M FY2023 · $58.3M FY2024 · $38.1M FY2025 · $73.5M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 1%
  • Free cash 4%
-5% 0% 10% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 2% · Free cash 9% FY2021 · Net 6% · Free cash 8% FY2022 · Net 3% · Free cash 0% FY2023 · Net -4% · Free cash 3% FY2024 · Net -2% · Free cash 2% FY2025 · Net 1% · Free cash 4%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $184.5M net debt
  • Cash
  • Long-term debt
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $373.9M · Long-term debt $624.6M FY2021 · Cash $305.8M · Long-term debt $543.6M FY2022 · Cash $229.4M · Long-term debt $546.2M FY2023 · Cash $149.9M · Long-term debt $437.7M FY2024 · Cash $73.9M · Long-term debt $239.1M FY2025 · Cash $38.7M · Long-term debt $223.2M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 79.42m -2.2% since FY2020
81.41m 78.31m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 81.24m FY2021 · 81.41m FY2022 · 78.99m FY2023 · 78.31m FY2024 · 78.78m FY2025 · 79.42m
  FY2020Jan 2, 2021 FY2021Jan 1, 2022 FY2022Dec 31, 2022 FY2023Dec 30, 2023 FY2024Dec 28, 2024 FY2025Jan 3, 2026
Revenue $1.7B $2.1B $1.6B $1.8B $1.8B $2.0B
Operating income $87.0M $174.9M $52.8M $24.5M -$10.4M $58.8M
Net income $36.3M $128.2M $42.1M -$65.9M -$28.5M $29.6M
Net margin 2% 6% 3% -4% -2% 1%
Earnings per share $0.44 $1.33 $0.52 -$0.84 -$0.36 $0.37
Free cash flow $158.2M $163.4M $5.7M $58.3M $38.1M $73.5M
Free cash margin 9% 8% 0% 3% 2% 4%
Cash $373.9M $305.8M $229.4M $149.9M $73.9M $38.7M
Long-term debt $624.6M $543.6M $546.2M $437.7M $239.1M $223.2M
Shareholders' equity $906.5M $926.0M $901.1M $829.4M $816.3M $869.5M
Shares outstanding 81.24m 81.41m 78.99m 78.31m 78.78m 79.42m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 13, 2026 Quarterly ↗ Jul 4, 2026 40d
May 14, 2026 Quarterly ↗ Apr 4, 2026 40d
Mar 4, 2026 Annual ↗ Jan 3, 2026 60d
Nov 6, 2025 Quarterly ↗ Sep 27, 2025 40d
Aug 7, 2025 Quarterly ↗ Jun 28, 2025 40d
May 8, 2025 Quarterly ↗ Mar 29, 2025 40d
Feb 26, 2025 Annual ↗ Dec 28, 2024 60d
Nov 6, 2024 Quarterly ↗ Sep 28, 2024 39d
Aug 7, 2024 Quarterly ↗ Jun 29, 2024 39d
May 8, 2024 Quarterly ↗ Mar 30, 2024 39d
Feb 27, 2024 Annual ↗ Dec 30, 2023 59d
Nov 9, 2023 Quarterly ↗ Sep 30, 2023 40d

Current reports

FiledDisclosed
Aug 12, 2026 Results ↗
Jun 22, 2026 Shareholder vote ↗
Jun 3, 2026 Regulation FD ↗
May 13, 2026 Results ↗
Mar 4, 2026 Results ↗
Dec 16, 2025 Material agreement ↗
Nov 5, 2025 Results ↗
Aug 6, 2025 Results ↗
Aug 4, 2025 Director or officer change ↗
Jun 23, 2025 Shareholder vote ↗
May 7, 2025 Results ↗
Apr 29, 2025 Director or officer change · Regulation FD ↗